Bhargava Aradhana, Nagia Sonal, Verma Prashant, Bansal Shikha, Khnuger Niti, Saxena Ashok
Apex Regional STD Centre, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Department of Dermatology and STD, Apex Regional STD Centre, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Indian J Sex Transm Dis AIDS. 2022 Jul-Dec;43(2):146-149. doi: 10.4103/ijstd.ijstd_30_22. Epub 2022 Aug 1.
According to the World Health Organization, 6 million cases of syphilis occur every year. Serological tests for syphilis form the mainstay of diagnosis for syphilis. We evaluated the performance of point-of-care test (POCT) against other specific treponemal test for confirming the diagnosis of syphilis.
Does performance and operational superiority of POCT make it the investigation of choice in confirming syphilis? Retrospectively, data were analyzed of 599 serum samples from Apex Regional sexually transmitted disease centre, Safdarjung Hospital, New Delhi, received for testing by syphilis treponemal assays (both nontreponemal reactive and nonreactive). These samples underwent treponemal testing for syphilis by the hemagglutination (TPHA), fluorescent treponemal antibody absorption test (FTA-ABS), and POCT. Performance characteristics (sensitivity, specificity, positive predictive value [PPV], negative predictive value [NPV], and diagnostic accuracy), and operational characteristics of POCT and TPHA were evaluated against the gold standard FTA-ABS.
A total of 599 samples were evaluated, of which 61.76% were positive by FTA-ABS. On analysis, the sensitivity was 91.08% and 91.89%, specificity was 89.08% and 87.34%, PPV was 93.09% and 92.14%, NPV was 86.08% and 86.96%, and diagnostic accuracy was 90.32% and 90.15% for POCT and TPHA, respectively. The lower cost, shorter turnaround time, lesser infrastructure and workforce need, and easy availability make the POCT operationally superior to TPHA.
Owing to its operational superiority and higher specificity POCT can replace TPHA for confirming the diagnosis of Syphilis. POCT are affordable, equipment free, have room temperature storage, and yield result within 15 minutes, enabling same day testing and treatment. It can be used in a resource limited setting, for community setup or even self-testing.
根据世界卫生组织的数据,每年有600万例梅毒病例。梅毒血清学检测是梅毒诊断的主要手段。我们评估了即时检验(POCT)与其他特定梅毒螺旋体检测方法在确诊梅毒方面的性能。
POCT的性能和操作优势是否使其成为确诊梅毒的首选检测方法?我们回顾性分析了新德里萨夫达容医院顶点地区性传播疾病中心接收的599份血清样本的数据,这些样本通过梅毒螺旋体检测(包括非梅毒螺旋体反应性和非反应性)进行检测。这些样本通过血凝试验(TPHA)、荧光梅毒螺旋体抗体吸收试验(FTA-ABS)和POCT进行梅毒螺旋体检测。以金标准FTA-ABS为对照,评估POCT和TPHA的性能特征(敏感性、特异性、阳性预测值[PPV]、阴性预测值[NPV]和诊断准确性)以及操作特征。
共评估了599份样本,其中FTA-ABS检测阳性的占61.76%。分析结果显示,POCT的敏感性分别为91.08%和91.89%,特异性分别为89.08%和87.34%,PPV分别为93.09%和92.14%,NPV分别为86.08%和86.96%,诊断准确性分别为90.32%和90.15%;TPHA的敏感性分别为91.08%和91.89%,特异性分别为89.08%和87.34%,PPV分别为93.09%和92.14%,NPV分别为86.08%和86.96%,诊断准确性分别为90.32%和90.15%。POCT成本更低、周转时间更短、所需基础设施和劳动力更少且易于获取,在操作上优于TPHA。
由于其操作优势和更高的特异性,POCT可替代TPHA用于确诊梅毒。POCT价格实惠、无需设备、可在室温下储存且15分钟内出结果,能够实现当天检测和治疗。它可用于资源有限的环境、社区环境甚至自我检测。